Las Vegas Review-Journal · Jul 2026
Profiles Vena Vitals’ Las Vegas expansion, lab footprint, headcount, investor support, and progress toward clinical trials and FDA approval.
A small sticker that monitors blood pressure continuously
Company research
Public company, workplace, funding, and market signals
Overview
Vena Vitals is a medical device startup developing VeriTrack, a soft skin-conforming wearable sticker for continuous, noninvasive blood pressure monitoring in operating rooms, sleep medicine, and clinical/home settings.
Primary product
VeriTrack continuous noninvasive blood pressure monitor
Founded
2019
Headquarters
Irvine, California, United States
Team size
10-20
Industry
Medical Device
Sub-industry
Continuous noninvasive blood pressure monitoring / wearable cardiovascular monitoring
Offices
Irvine, California, United States (HQ; Cove at UCI / University LabPartners lab space)
Las Vegas, Nevada, United States (Roseman Bioventures lab/incubator)
Business model
B2B medical device sales
Disposable sensor / hardware sales
Hospital and clinical channel sales
Sleep and home monitoring expansion
Funding
Stage
Series A
Total raised
$10.7M
Latest round
Series A · May 2025
Latest amount
$10M
People & investors
Founders
Co-Founder
Investors
AME Cloud Ventures
Desert Forge Ventures
Draper Associates
First Star Ventures
Hustle Fund
Innospark Ventures
Locus Ventures
MedTech Innovator
Morado Ventures
National Institutes of Health / NHLBI
National Science Foundation
Pitch Launch Grow Competition
Samsung
Soma Capital
Y Combinator
Y Combinator Continuity Fund
Work & culture
Mission-driven, small early-stage startup culture; fast-paced, hands-on, encouraging, and dynamic; heavy collaboration with hospital systems, lab work, and clinical validation.
Visa sponsorship
Yes
Compensation
Public YC job postings show base salary bands of roughly $60K-$150K depending on role, plus equity on some roles (about 0.09%-0.50%).
Product & market
Pricing
Not publicly disclosed; evidence suggests B2B medical-device pricing for hospitals/clinical customers, with disposable sensor hardware and future sleep/home products.
Differentiators
- —Continuous beat-to-beat blood pressure monitoring
- —No cuff, no needles, noninvasive wearable sticker
- —Soft, skin-conforming form factor
- —Patented wrinkled metal capacitive sensing material
- —Placed over a palpable artery and out of the surgical field
- —Positioned as a lower-cost alternative to invasive arterial lines
- —Bluetooth-enabled data capture and real-time analytics
Technology
soft stretchable sensors
patented wrinkled metal technology
capacitive pressure sensor
Bluetooth data transmission
MATLAB
Python
LabVIEW
C
C++
scikit-learn
TensorFlow
PyTorch
Customers
Hospitals
Operating room teams
ICU / critical care teams
Anesthesiologists
Sleep physicians
Clinical researchers
Competitors
Edwards ClearSight
Blumio
Tensys
Eko
Tricog
Ultromics
Hilo
Biobeat
Omron Healthcare
Valencell
Scale & contact
Estimated revenue
$3M-$5M estimated ARR
Estimated monthly visits
6.2K
Traffic estimate as of Jul 2026
Latest news
UC Irvine Samueli School of Engineering · Feb 2026
Another UCI profile with details on the founding team, clinical testing, university support, and path toward FDA clearance.
UCI Beall Applied Innovation · Feb 2026
Explains the company’s UC Irvine origins, continuous blood pressure sticker, lab/incubator space, clinical validation, and early customer discovery.
Vena Vitals LinkedIn · Oct 2025
Company post stating Ray Liu and Josh Kim showed the latest product and announced FDA 510(k) submission.
SBIR / NIH · Sep 2025
Documents a $306,872 NIH SBIR Phase I award for VeriSleep, a wearable for continuous blood pressure monitoring during sleep.
Jobs and careers at Vena Vitals
0 jobs at Vena Vitals
No open positions
Check back later for new openings